Sort
82,697 grants matching “vaccine development”
Clinical Trials of Biodefense Vaccines (Dengue)
$2,489,695Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
GENERAL CLINICAL RESEARCH CENTER
$2,489,323E Albert Reece · University Of Maryland Baltimore · M01 · FY2006 · RR
mAbs and vaccines against SARS CoV-2
$2,487,506Nancy J Sullivan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Vanderbilt HIV Clinical Trials Unit
$2,487,433David W Haas · Vanderbilt University Medical Center · UM1 · FY2020 · AI
IMPAACT RELATED PROTOCOLS FOR THE RESEARCH ON TREATMENT, PREVENTION, DIAGNOSIS AND EPIDEMIOLOGY OF HIV INFECTIONS
$2,486,704Barbara Driver · Westat, Inc. · N01 · FY2021 · HD
Translational Immunology Research and Accelerated [vaccine] Development (TRIAD)
$2,486,017Anne Searls De Groot · University Of Rhode Island · U19 · FY2009 · AI
DEVELOPMENT OF ANTHRAX VACCINE FORMULATI0N
$2,484,726Laurence Lemiale · Emergent Product Development Gaithersbur · N01 · FY2018 · AI
Viral Respiratory Pathogens Research Unit
$2,484,680Robert B Couch · Baylor College Of Medicine · N01 · FY2011 · AI
Phase II Clinical Trial to Evaluate a Vaccine for Gonorrhea
$2,484,021National Institute Of Allergy And Infectious Diseases · Y01 · FY2023 · AI
NIDA Clinical Trials Network: Greater New York Node
$2,483,943John P Rotrosen · New York University School Of Medicine · UG1 · FY2017 · DA
The humoral response to Zika virus infection and vaccination
$2,483,688Theodore Pierson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
CANOE Partnership: Cancer Awareness, Navigation, Outreach, and Equitable Indigenous Health Outcomes
$2,483,619Lonnie A. Nelson · Fred Hutchinson Cancer Center · U19 · FY2024 · MD
Dana Farber/Harvard Cancer Center Ovarian Cancer SPORE grant
$2,483,069Alan David D'andrea · Dana-Farber Cancer Inst · P50 · FY2020 · CA
Pulmonary innate immune activation for bioterror defense
$2,482,689Coley Pharmaceutical Group, Inc. · U01 · FY2004 · AI
Core C: Biosecurity Core
$2,481,967James W. Leduc · University Of Texas Med Br Galveston · UC7 · FY2023 · AI
Immune Monitoring
$2,481,595Clive Maurice Gray · Duke University · U19 · FY2010 · AI
Biodefense and Emerging Infectious Disease Monoclonal Antibody Studies
$2,481,382Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Pre-clinical Vaccine Development for Emerging and Re-emerging Infectious Diseases
$2,480,852Wing Pui Kong · National Institute Of Allergy And Infectious Diseases · ZIC · FY2023 · AI
Pre-clinical Vaccine Development for Emerging and Re-emerging Infectious Diseases
$2,480,852Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIC · FY2022 · AI
Pre-clinical Vaccine Development for Respiratory Viruses
$2,480,852Wing Pui Kong · National Institute Of Allergy And Infectious Diseases · ZIC · FY2023 · AI
Pre-clinical Vaccine Development for Respiratory Viruses
$2,480,852Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIC · FY2022 · AI
University of Puerto Rico Clinical Trials Unit
$2,480,642Carmen D Zorrilla · University Of Puerto Rico Med Sciences · U01 · FY2009 · AI
NCI-Frederick Support and Technical Services
$2,480,548Kristin Komschlies McConville · Office Of The Director, Nci · ZIC · FY2022 · CA
Structural Biology Core
$2,480,350Richard J. Kuhn · Vanderbilt University Medical Center · U19 · FY2024 · AI
Tissue compartmentalization of human lymphocytes
$2,479,991Donna L Farber · Columbia University Health Sciences · P01 · FY2014 · AI